The Alzheimer’s Association has announced a $4.3 million research grant to support a new phase of the Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU) known as DIAN-TU Next Generation (NexGen). The award will accelerate testing of potential Alzheimer’s disease (AD) therapies, as well as testing of new diagnostic approaches, in people with genetically based, younger-onset AD or dominantly inherited AD (DIAD) using an innovative trial design that is being applied to AD. DIAN-TU is a landmark, global AD prevention study led by researchers at Washington University in St.
from Dementia Big http://ift.tt/2b3xf4N via alcoholic dementia
http://ift.tt/2b0tDAc
No comments:
Post a Comment